Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$11.80 -0.10 (-0.84%)
As of 02:11 PM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$11.80
C$11.80
50-Day Range
C$10.75
C$12.00
52-Week Range
C$9.20
C$12.13
Volume
100 shs
Average Volume
4,284 shs
Market Capitalization
C$134.96 million
P/E Ratio
19.15
Dividend Yield
1.53%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

RX Stock News Headlines

Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
BioSyent Inc. (RX.V)
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of the year. Since then, RX stock has increased by 7.3% and is now trading at C$11.80.

BioSyent Inc. (CVE:RX) issued its earnings results on Thursday, May, 25th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $3.82 million for the quarter, compared to the consensus estimate of $4.80 million. BioSyent had a trailing twelve-month return on equity of 20.01% and a net margin of 20.60%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
19.15
Forward P/E Ratio
16.99
P/E Growth
N/A
Net Income
C$7.02 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$34.06 million
Cash Flow
C$3.84 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.66

Miscellaneous

Free Float
N/A
Market Cap
C$134.96 million
Optionable
Not Optionable
Beta
0.93
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:RX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners